BridgeBio to present at major healthcare investor conferences in May and June 2026

BridgeBio Pharma, a biopharmaceutical company focused on genetic conditions, announced its management will participate in investor conferences in May and June 2026. The events include the BofA Securities Health Care Conference on May 12, the Jefferies Global Healthcare Conference on June 4, and the Goldman Sachs Global Healthcare Conference on June 9. These presentations will be webcast live and available for replay on BridgeBio's investor website. This participation highlights BridgeBio's ongoing efforts to engage investors and showcase its progress in developing medicines for genetic diseases.